OTTIENI UNA VALUTAZIONE GRATUITA IN 24 ORE CLICK HERE X Dismiss
Global lower-middle market M&A Advisors
Countries in which we've closed transactions
Languages spoken by our Team
Total deals value
Global lower-middle market M&A Advisors
Countries in which we've closed transactions
Languages spoken by our Team
Total deals value
© 2024 MergersCorp M&A International.
© 2024 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States.
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
Biotech business with an excellent safety record of more than 2500 clinical treatments. Company designs, manufactures, and markets affinity blood filtration products. A new and highly innovative hemofiltration device that uses pat ...
The Indian pharmaceutical industry has emerged as a global player in the past few decades, becoming one of the largest producers of generic drugs worldwide. The business of Indian pharmaceuticals has witnessed exponential ...
This Pharmaceutical Manufacturing Company was founded around 40-Year-Old in Amman, Jordan. It holds the regional benchmark in innovation with more than 70 patents. As direct result of this innovation, operations were diversifie ...
The company was founded in the district Punjab India, 1982 with a purpose of manufacturing Active Pharmaceutical Ingredients. The company is an active pharmaceutical ingredient (API) manufacturing company that manufactures the ...
This company has been in the Colombian market for 19 years, it owns the approved INVIMA registrations. There is a serious conversations to expand market to Guatemala and 5 more countries in Central America with one big distribu ...
This company for sale is a healthcare company based in Bangalore, India. The business is involved in the manufacturing and supply of medicines and nutritional supplements to people across the globe (Quality standards as specified ...
Pharma Businesses for Sale, Find the Best Established Pharma Businesses for Sale, Pharma Businesses for Sale Marketplace, Buy a Pharma Business in, Pharma Companies for Sale, Discover opportunities for entrepreneurs in the United States, Pharma Companies for sale. Browse the Best Pharma Businesses for Sale Available to Buy Now, Pharma Business for Sale, Explore Pharma Business for Sale, Pharma Business for Sale, Pharma Business Opportunities.
Biotech business with an excellent safety record of more than 2500 clinical treatments. Company designs, manufactures, and markets affinity blood filtration products. A new and highly innovative hemofiltration device that uses patented and proprietary biomimetic technology to quickly remove bacteria, fungi, bacterial toxins, viruses, proinflammatory cytokines, and sepsis mediators from a patient who is afflicted with bloodstream infection.
Investment Appeal
Millions of patients affected globally sepsis market north of 30 million cases each year.
Other applications of this technology may be used as a countermeasure for bioweapons attack (COVID), PDAC cancer, to prevent the side effects of the use of ECMO and cardiopulmonary bypass in diagnostics, blood banking, and bioprocessing.
Just 10x trailing net income could value the company up to $40 Billion by the end of 2028.
Growth Opportunity
Strong Management
Gross Profit Margins >85%
© 2024 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States.
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
This website is operated by MergersUS Inc a US Corporation with registered office at
Error: Contact form not found.
Error: Contact form not found.
Error: Contact form not found.
Error: Contact form not found.